Chemical Research in Toxicology
Article
(17) Vance, J. E., and Tasseva, G. (2013) Formation and function of
phosphatidylserine and phosphatidylethanolamine in mammalian cells.
Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1831, 543−554.
(18) Li, W., Laird, J. M., Lu, L., Roychowdhury, S., Nagy, L. E., Zhou,
R., Crabb, J. W., and Salomon, R. G. (2009) Isolevuglandins covalently
modify phosphatidylethanolamines in vivo: detection and quantitative
analysis of hydroxylactam adducts. Free Radical Biol. Med. 47, 1539−
1552.
(19) Zemski Berry, K. A., and Murphy, R. C. (2007) Characterization
of acrolein-glycerophosphoethanolamine lipid adducts using electro-
spray mass spectrometry. Chem. Res. Toxicol. 20, 1342−1351.
(20) Guo, L., Chen, Z., Cox, B. E., Amarnath, V., Epand, R. F., Epand,
R. M., and Davies, S. S. (2011) Phosphatidylethanolamines modified
by gamma-ketoaldehyde (gammaKA) induce endoplasmic reticulum
stress and endothelial activation. J. Biol. Chem. 286, 18170−18180.
(21) Wang, H., Guo, J., West, X. Z., Bid, H. K., Lu, L., Hong, L., Jang,
G. F., Zhang, L., Crabb, J. W., Linetsky, M., and Salomon, R. G. (2014)
Detection and biological activities of carboxyethylpyrrole ethanol-
amine phospholipids (CEP-EPs). Chem. Res. Toxicol. 27, 2015−2022.
(22) Sullivan, C. B., Matafonova, E., Roberts, L. J., 2nd, Amarnath, V.,
and Davies, S. S. (2010) Isoketals form cytotoxic phosphatidylethanol-
amine adducts in cells. J. Lipid Res. 51, 999−1009.
(23) Lu, L., Gu, X., Hong, L., Laird, J., Jaffe, K., Choi, J., Crabb, J.,
and Salomon, R. G. (2009) Synthesis and structural characterization of
carboxyethylpyrrole-modified proteins: mediators of age-related
macular degeneration. Bioorg. Med. Chem. 17, 7548−7561.
(24) Globisch, M., Kaden, D., and Henle, T. (2015) 4-Hydroxy-2-
nonenal (4-HNE) and Its Lipation Product 2-Pentylpyrrole Lysine (2-
PPL) in Peanuts. J. Agric. Food Chem. 63, 5273−5281.
(25) Nur, E., Biemond, B. J., Otten, H. M., Brandjes, D. P., and
Schnog, J. J. (2011) Oxidative stress in sickle cell disease;
pathophysiology and potential implications for disease management.
Am. J. Hematol. 86, 484−489.
enoic acid; LA, linoleic acid; PLD, phospholipase D; PP, 2-
pentylpyrrole; PP-ETN, 2-(2-pentyl-1H-pyrrol-1-yl)ethan-1-ol;
PP-ETN-d4, 2-(2-pentyl-1H-pyrrol-1-yl)ethan-1,1,2,2-d4-1-ol;
PUFA, polyunsaturated fatty acid; SCD, sickle cell disease;
SUV, small unilammelar vesicle; TLR, Toll-like receptor
REFERENCES
■
(1) Uchida, K. (2003) Histidine and lysine as targets of oxidative
modification. Amino Acids 25, 249−257.
(2) Sayre, L. M., Lin, D., Yuan, Q., Zhu, X., and Tang, X. (2006)
Protein adducts generated from products of lipid oxidation: focus on
HNE and one. Drug Metab. Rev. 38, 651−675.
(3) Catala, A. (2006) An overview of lipid peroxidation with
emphasis in outer segments of photoreceptors and the chemilumi-
nescence assay. Int. J. Biochem. Cell Biol. 38, 1482−1495.
(4) Guichardant, M., Taibi-Tronche, P., Fay, L. B., and Lagarde, M.
(1998) Covalent modifications of aminophospholipids by 4-hydrox-
ynonenal. Free Radical Biol. Med. 25, 1049−1056.
(5) Bernoud-Hubac, N., Fay, L. B., Armarnath, V., Guichardant, M.,
Bacot, S., Davies, S. S., Roberts, L. J., 2nd, and Lagarde, M. (2004)
Covalent binding of isoketals to ethanolamine phospholipids. Free
Radical Biol. Med. 37, 1604−1611.
(6) Kaur, K., Salomon, R. G., O’Neil, J., and Hoff, H. F. (1997)
(Carboxyalkyl)pyrroles in human plasma and oxidized low-density
lipoproteins. Chem. Res. Toxicol. 10, 1387−1396.
(7) Choi, J., Zhang, W., Gu, X., Chen, X., Hong, L., Laird, J. M., and
Salomon, R. G. (2011) Lysophosphatidylcholine is generated by
spontaneous deacylation of oxidized phospholipids. Chem. Res. Toxicol.
24, 111−118.
(8) Salomon, R. G., and Gu, X. (2011) Critical insights into
cardiovascular disease from basic research on the oxidation of
phospholipids: the gamma-hydroxyalkenal phospholipid hypothesis.
Chem. Res. Toxicol. 24, 1791−1802.
(9) Bacot, S., Bernoud-Hubac, N., Baddas, N., Chantegrel, B.,
Deshayes, C., Doutheau, A., Lagarde, M., and Guichardant, M. (2003)
Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE
to ethanolamine phospholipid subclasses. J. Lipid Res. 44, 917−926.
(10) Sayre, L. M., Sha, W., Xu, G., Kaur, K., Nadkarni, D.,
Subbanagounder, G., and Salomon, R. G. (1996) Immunochemical
evidence supporting 2-pentylpyrrole formation on proteins exposed to
4-hydroxy-2-nonenal. Chem. Res. Toxicol. 9, 1194−1201.
(11) Salomon, R. G., Kaur, K., Podrez, E., Hoff, H. F., Krushinsky, A.
V., and Sayre, L. M. (2000) HNE-derived 2-pentylpyrroles are
generated during oxidation of LDL, are more prevalent in blood
plasma from patients with renal disease or atherosclerosis, and are
present in atherosclerotic plaques. Chem. Res. Toxicol. 13, 557−564.
(12) Salomon, R. G., Hong, L., and Hollyfield, J. G. (2011) Discovery
of carboxyethylpyrroles (CEPs): critical insights into AMD, autism,
cancer, and wound healing from basic research on the chemistry of
oxidized phospholipids. Chem. Res. Toxicol. 24, 1803−1816.
(13) Gu, X., Meer, S. G., Miyagi, M., Rayborn, M. E., Hollyfield, J. G.,
Crabb, J. W., and Salomon, R. G. (2003) Carboxyethylpyrrole protein
adducts and autoantibodies, biomarkers for age-related macular
degeneration. J. Biol. Chem. 278, 42027−42035.
(14) Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A.,
Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon,
R. G., and Hollyfield, J. G. (2002) Drusen proteome analysis: an
approach to the etiology of age-related macular degeneration. Proc.
Natl. Acad. Sci. U. S. A. 99, 14682−14687.
(15) Ebrahem, Q., Renganathan, K., Sears, J., Vasanji, A., Gu, X., Lu,
L., Salomon, R. G., Crabb, J. W., and Anand-Apte, B. (2006)
Carboxyethylpyrrole oxidative protein modifications stimulate neo-
vascularization: Implications for age-related macular degeneration.
Proc. Natl. Acad. Sci. U. S. A. 103, 13480−13484.
(26) Chirico, E. N., and Pialoux, V. (2012) Role of oxidative stress in
the pathogenesis of sickle cell disease. IUBMB Life 64, 72−80.
(27) Akohoue, S. A., Shankar, S., Milne, G. L., Morrow, J., Chen, K.
Y., Ajayi, W. U., and Buchowski, M. S. (2007) Energy expenditure,
inflammation, and oxidative stress in steady-state adolescents with
sickle cell anemia. Pediatr. Res. 61, 233−238.
(28) Wood, K. C., and Granger, D. N. (2007) Sickle cell disease: role
of reactive oxygen and nitrogen metabolites. Clin. Exp. Pharmacol.
Physiol. 34, 926−932.
(29) Francis, R. B., Jr. (1991) Platelets, coagulation, and fibrinolysis
in sickle cell disease: their possible role in vascular occlusion. Blood
Coagulation Fibrinolysis 2, 341−353.
(30) De Franceschi, L., Cappellini, M. D., and Olivieri, O. (2011)
Thrombosis and sickle cell disease. Semin. Thromb. Hemostasis 37,
226−236.
(31) Tomer, A., Harker, L. A., Kasey, S., and Eckman, J. R. (2001)
Thrombogenesis in sickle cell disease. J. Lab. Clin. Med. 137, 398−407.
(32) Panigrahi, S., Ma, Y., Hong, L., Gao, D., West, X. Z., Salomon, R.
G., Byzova, T. V., and Podrez, E. A. (2013) Engagement of platelet
toll-like receptor 9 by novel endogenous ligands promotes platelet
hyperreactivity and thrombosis. Circ. Res. 112, 103−112.
(33) Biswas, S., Xin, L., Panigrahi, S., Zimman, A., Wang, H.,
Yakubenko, V., Byzova, T. V., Salomon, R. G., and Podrez, E. A.
(2016) Novel phosphatidylethanolamine derivatives accumulate in
circulation in hyperlipidemic ApoE−/− mice and activate platelets via
TLR2. Blood 127, 2618−29.
(34) Gaarder, A., Jonsen, J., Laland, S., Hellem, A., and Owren, P. A.
(1961) Adenosine diphosphate in red cells as a factor in the
adhesiveness of human blood platelets. Nature 192, 531−532.
(35) Proenca-Ferreira, R., Franco-Penteado, C. F., Traina, F., Saad, S.
T., Costa, F. F., and Conran, N. (2010) Increased adhesive properties
of platelets in sickle cell disease: roles for alphaIIb beta3-mediated
ligand binding, diminished cAMP signalling and increased phospho-
diesterase 3A activity. Br. J. Haematol. 149, 280−288.
(16) West, X. Z., Malinin, N. L., Merkulova, A. A., Tischenko, M.,
Kerr, B. A., Borden, E. C., Podrez, E. A., Salomon, R. G., and Byzova,
T. V. (2010) Oxidative stress induces angiogenesis by activating TLR2
with novel endogenous ligands. Nature 467, 972−976.
(36) Villagra, J., Shiva, S., Hunter, L. A., Machado, R. F., Gladwin, M.
T., and Kato, G. J. (2007) Platelet activation in patients with sickle
J
Chem. Res. Toxicol. XXXX, XXX, XXX−XXX